Iridex Corp last reported quarterly results on Aug 18, 2026, for Q2 FY2026 (the quarter ended Jul 4, 2026): revenue of $12.6 million (-7.4% year over year) and diluted EPS of -$0.07. It usually reports 9–46 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 11, 2026.
Results for Q3 FY2026, the quarter ending around Sep 26, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Nov 12, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 9–46 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 18, 2026
45 days after quarter end
|
Q2 FY2026
ended Jul 4, 2026
|
13
-7.4%
|
-1
-27.4%
|
-0.07
-16.7%
|
|
May 19, 2026
45 days after quarter end
|
Q1 FY2026
ended Apr 4, 2026
|
12
-0.8%
|
-1
+68.9%
|
-0.03
+70.0%
|
|
Jan 12, 2026
9 days after quarter end
|
Q4 FY2025
ended Jan 3, 2026
|
—
|
—
|
—
|
|
Nov 12, 2025
46 days after quarter end
|
Q3 FY2025
ended Sep 27, 2025
|
12
+7.8%
|
-2
+18.6%
|
-0.09
+25.0%
|
|
Aug 12, 2025
45 days after quarter end
|
Q2 FY2025
ended Jun 28, 2025
|
14
+7.4%
|
-1
+62.9%
|
-0.06
+62.5%
|
|
Apr 14, 2025
16 days after quarter end
|
Q1 FY2025
ended Mar 29, 2025
|
12
+1.1%
|
-2
+51.3%
|
-0.10
+52.4%
|
|
Jan 14, 2025
17 days after quarter end
|
Q4 FY2024
ended Dec 28, 2024
|
13
+1.9%
|
-1
+71.8%
|
-0.05
+72.5%
|
|
Nov 12, 2024
45 days after quarter end
|
Q3 FY2024
ended Sep 28, 2024
|
12
-9.9%
|
-2
-10.2%
|
-0.12
-9.1%
|
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- IRIX (Nasdaq)
- Fiscal year ends
- January 3
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1006045
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.